COVID-19: CDC, FDA and CMS Guidance

This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.

The Food and Drug Administration added dexamethasone sodium phosphate to its lists for temporary compounding by outsourcing facilities and pharmacy compounders during the COVID-19 emergency.
Two new case studies affirm that cloth face coverings “are a critical tool in the fight against COVID-19 that could reduce the spread of the disease, particularly when used universally within communities,” the Centers for Disease Control and Prevention said.
The Food and Drug Administration authorized emergency use for a non-invasive nerve stimulator at home or in health care settings to treat suspected COVID-19 patients experiencing worsened asthma-related shortness of breath and reduced airflow.
Following yesterday’s announcement of changes to its process for collecting daily COVID-19-related data from hospitals, the Department of Health and Human Services (HHS) today asked hospitals to prioritize the reporting of seven data fields starting tomorrow, July 15.
The Food and Drug Administration authorized the University of California San Francisco’s Clinical Labs at China Basin to use a new molecular-based diagnostic test for SARS-CoV-2.
The Centers for Disease Control and Prevention released guidance for emergency medical planners and health care facilities on identifying relief health care facilities, and establishing or using medical operation coordination cells to improve surge capacity and resource allocation during the COVID-…
The Food and Drug Administration authorized the emergency use of the BD (Becton Dickinson) Veritor System for Rapid Detection of SARS-CoV-2.
The Food and Drug Administration warned of methanol’s toxic and “not acceptable” suitability for use as an active ingredient in hand sanitizer. Methanol is a wood alcohol more commonly used for the creation of fuel or antifreeze. FDA said it has seen an increase in methanol’s use in hand sanitizers…
The Food and Drug Administration and Centers for Disease Control and Prevention July 7 at 12 p.m. ET will host a webinar on decontaminating respirators for health care personnel during the COVID-19 pandemic.